Isabelle de Monestrol

1.1k total citations
17 papers, 263 citations indexed

About

Isabelle de Monestrol is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Isabelle de Monestrol has authored 17 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 3 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Isabelle de Monestrol's work include Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (6 papers) and Tracheal and airway disorders (5 papers). Isabelle de Monestrol is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (6 papers) and Tracheal and airway disorders (5 papers). Isabelle de Monestrol collaborates with scholars based in Sweden, Italy and Russia. Isabelle de Monestrol's co-authors include Lena Hjelte, Lars Holmberg, Magnus Johannesson, R Kornfält, Anders Lindblad, Birgitta Strandvik, Lena Klingspor, Peter Bergman, H Kollberg and Kimmo Sorjonen and has published in prestigious journals such as Archives of Disease in Childhood, Analytical and Bioanalytical Chemistry and British Journal of Clinical Pharmacology.

In The Last Decade

Isabelle de Monestrol

16 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle de Monestrol Sweden 8 220 40 33 32 23 17 263
Atqah Abdul Wahab Qatar 12 172 0.8× 65 1.6× 28 0.8× 33 1.0× 38 1.7× 32 307
Barbara Messore Italy 10 337 1.5× 60 1.5× 40 1.2× 17 0.5× 43 1.9× 18 401
Rosaria Casciaro Italy 12 280 1.3× 52 1.3× 40 1.2× 26 0.8× 53 2.3× 29 354
K. Gyi United Kingdom 8 218 1.0× 33 0.8× 48 1.5× 28 0.9× 19 0.8× 14 257
C. Shortt Ireland 7 295 1.3× 45 1.1× 13 0.4× 27 0.8× 99 4.3× 14 351
Martina Contarini Italy 11 309 1.4× 72 1.8× 21 0.6× 16 0.5× 33 1.4× 21 372
Jill M. VanDalfsen United States 8 316 1.4× 33 0.8× 16 0.5× 15 0.5× 27 1.2× 11 335
Bernadette Prentice Australia 11 199 0.9× 38 0.9× 54 1.6× 16 0.5× 25 1.1× 26 269
Paul H. Sammut United States 10 228 1.0× 45 1.1× 83 2.5× 27 0.8× 23 1.0× 17 318

Countries citing papers authored by Isabelle de Monestrol

Since Specialization
Citations

This map shows the geographic impact of Isabelle de Monestrol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle de Monestrol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle de Monestrol more than expected).

Fields of papers citing papers by Isabelle de Monestrol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle de Monestrol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle de Monestrol. The network helps show where Isabelle de Monestrol may publish in the future.

Co-authorship network of co-authors of Isabelle de Monestrol

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle de Monestrol. A scholar is included among the top collaborators of Isabelle de Monestrol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle de Monestrol. Isabelle de Monestrol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Sorjonen, Kimmo, et al.. (2024). Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden. Therapeutic Advances in Respiratory Disease. 18. 2693833418–2693833418. 2 indexed citations
3.
Imberg, Henrik, et al.. (2024). Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study. Pediatric Pulmonology. 59(11). 2967–2975. 4 indexed citations
5.
Wadström, Hjalmar, et al.. (2024). Development and clinical implementation of an LC-HRMS method for ivacaftor, lumacaftor, tezacaftor and elexacaftor in human plasma and breast milk. Analytical and Bioanalytical Chemistry. 416(26). 5565–5577. 2 indexed citations
6.
Colombo, Carla, Grant A. Ramm, Anders Lindblad, et al.. (2023). Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators. Journal of Cystic Fibrosis. 22(2). 263–265. 4 indexed citations
7.
Monestrol, Isabelle de, et al.. (2022). Antibiotic hypersensitivity in cystic fibrosis – Low frequency of anaphylaxis over 16 000 courses. British Journal of Clinical Pharmacology. 88(11). 4845–4853. 7 indexed citations
8.
Colombo, Carla, Gianfranco Alicandro, Mark Oliver, et al.. (2021). Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study. Journal of Cystic Fibrosis. 21(2). 220–226. 21 indexed citations
9.
Sorjonen, Kimmo, et al.. (2021). The Effects of Aspergillus fumigatus Colonization on Lung Function in Patients with Cystic Fibrosis. Journal of Fungi. 7(11). 944–944. 10 indexed citations
10.
Klingspor, Lena, et al.. (2020). A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function. International Journal of Infectious Diseases. 96. 663–670. 17 indexed citations
11.
Monestrol, Isabelle de, et al.. (2018). Experiences of Individuals Awaiting Lung Transplantation. Respiratory Care. 63(12). 1535–1540. 7 indexed citations
12.
Kaditis, Athanasios G., Michael Miligkos, Anna Bossi, et al.. (2017). Effect of allergic bronchopulmonary aspergillosis on FEV1in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis. Archives of Disease in Childhood. 102(8). 742–747. 9 indexed citations
13.
Monestrol, Isabelle de. (2014). WS23.5 Clinical importance of homozygous R117C (c.349C>T) CFTR mutation. Journal of Cystic Fibrosis. 13. S44–S44. 1 indexed citations
14.
Monestrol, Isabelle de, Åsa Klint, Pär Sparén, & Lena Hjelte. (2011). Age at diagnosis and disease progression of cystic fibrosis in an area without newborn screening. Paediatric and Perinatal Epidemiology. 25(3). 298–305. 4 indexed citations
15.
Monestrol, Isabelle de, Agneta Bergsten Brucefors, Birgitta Janerot-Sjöberg, & Lena Hjelte. (2010). Parental support for newborn screening for cystic fibrosis. Acta Paediatrica. 100(2). 209–215. 8 indexed citations
16.
Monestrol, Isabelle de, Lena Hjelte, Magnus Johannesson, et al.. (2002). Predictors of deterioration of lung function in cystic fibrosis*. Pediatric Pulmonology. 33(6). 483–491. 144 indexed citations
17.
Hjelte, Lena, Isabelle de Monestrol, Magnus Johannesson, et al.. (1999). Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden. Clinical Genetics. 56(4). 318–322. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026